The Cancer Letter

Inside information on cancer research and drug development

Vol.
30
No.
44
November 19, 2004Nov 19, 2004
Free
DOWNLOAD THE PDF

NCI advisors approve recompetition of $62 million phase II contracts program.

Also AIDS Malignancy Consortium grants to be consolidated on recompetition to one central group chairman’s office.

Advisors approve set-aside for alternative medicine “best case series.”

HHS bans tobacco from its campuses, opens national quitline, 1-800-QUITNOW.

Two founding cancer center directors step down: Harold Moses at Vanderbilt-Ingram and Charles Coltman at CTRC.

Funding opportunities listed.

November issue of Business & Regulatory Report, an additional 8 pages, included in this issue.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account